SIZE XSSIZE SMSIZE MDSIZE LG

BCOP Preparatory and Recertification Course

The HOPA Preparatory and Recertification Course is designed to prepare oncology pharmacists to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete an Preparatory Review/Recertification Course at least once, but no more than three times, during their 7-year BCOP recertification cycle.

The HOPA Preparatory and Recertification Course will offer 28 hours of BCOP recertification credit and will be made available on demand. The course will consist of content outlines in addition to webinars and podcasts.

bcop infographic updt

 

Pre-Order Now

 

The HOPA Preparatory and Recertification Course will be divided into 6 parts as shown below. Click on each topic to learn more.

Part I (5.5 hours)

Part II (5.5 hours)

Part III (6 hours)

Part IV (5.5 hours)

Part V (5.5 hours)

Part VI (5.5 hours)

*ACPE credit only

 

Legend

self study icon Self Study Outline

Webinar icon Webinar

bcop podcast icon Podcast

 

Pre-Order Now

Credit Designation

Accreditation Statement:

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by June 1, 2021.

education speaker bpslogo The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form, and post-test, with a combined passing grade of 75% or greater is achieved. Tests must be completed by June 1, 2021.

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

Reported Areas of Conflict: Planners and Managers Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.

For more information about BCOP certification and recertification, click here.

xs
sm
md
lg